Latest Articles

From Registry to Reality: Reduced Stroke Incidence with Agalsidase Beta in Fabry Disease

Tolerability of Accelerated Agalsidase Beta Infusions in Fabry Disease: The SHORTEN Study Analysis

Fabry Disease in Cardiology Practice: From Red Flags to Diagnosis

GvHD in Focus Risk Factors and Symptoms

This educational video highlights chronic Graft‑versus‑Host Disease (cGvHD), a long‑term complication following allogeneic stem cell transplantation. It outlines key risk factors for cGVHD and demonstrates common clinical manifestations affecting skin, eyes, mouth, lungs, joints, GI tract, scalp, liver, and Fascia. The video emphasizes early recognition to support timely management and improved long‑term outcomes.

Real-World Effectiveness of Nirsevimab: Evidence from the NIRSE-GAL Study

The NIRSE-GAL study is an ongoing population-based, prospective, longitudinal study conducted in Galicia, Spain. It includes infants eligible to receive nirsevimab and evaluates its impact on RSV-related outcomes in both inpatient and outpatient healthcare settings.

GvHD Unpacked: A Guide to Classifications and Mechanisms

This video provides a clear overview of graft-versus-host disease, exploring its key classifications and the underlying immunological mechanisms that drive disease development and progression. It aims to support understanding of GvHD pathophysiology to inform diagnosis, management, and therapeutic decision-making.

Expanding RSV Protection in Kuwait: New National Directives for Monoclonal Antibody Use

Summary of Kuwait’s updated RSV prevention policy

IL-4/IL-13 Dual Cytokine Signaling in Severe Asthma: Mechanistic Insights by Prof. Kenneth Chapman

Recognizing the key cytokines driving type 2 inflammation and understanding their profound impact on patients’ asthma burden is crucial.^1-3